GlassScriptPhysician profile
Alysia M Bedgood
NPI 1265660724
$673.60
in general payments reported to CMS, 2019-2025
15 companies · $26.29 in 2025
The $26.29 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.29 · 2022: $99.51 · 2023: $294 · 2024: $229 · 2025: $26.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.01 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $113.14 | 2023-2025 | Azstarys |
| Abbott Laboratories | $103.92 | 2022-2024 | Freestyle Libre 2, Proclaim |
| Abbvie INC. | $79.64 | 2022-2023 | Ubrelvy, Qulipta |
| Supernus Pharmaceuticals, INC. | $78.87 | 2023-2024 | Qelbree, Qelbree |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.35 | 2023 | Jardiance |
| Lilly USA, LLC | $44.38 | 2022-2024 | Jardiance, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $30.61 | 2024 | Trintellix |
| Dexcom, INC. | $29.06 | 2024 | Dexcom G6 Transmitter |
| Bioventus LLC | $29.05 | 2024-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Astrazeneca Pharmaceuticals LP | $28.65 | 2024 | Airsupra |
| Shield Therapeutics INC | $24.77 | 2023 | Accrufer |
| Genentech USA, INC. | $24.29 | 2021 | |
| Si-Bone, INC. | $17.50 | 2023 | |
| Exact Sciences Corporation | $13.58 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $0.79 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alysia Bedgood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.